Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2Myeloid 1Lymphoid 1CNS 1

Conditions

Leukemia 40Myelodysplastic Syndromes 38Leukemia, Myeloid, Acute 34Lymphoma 31Leukemia, Lymphocytic, Chronic, B-Cell 31Lymphoma, Non-Hodgkin 28Hodgkin Disease 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Multiple Myeloma 25Myeloproliferative Disorders 21Lymphoma, Large B-Cell, Diffuse 21Lymphoma, Follicular 21Lymphoma, B-Cell, Marginal Zone 21Lymphoma, Mantle-Cell 20Lymphoma, Large-Cell, Immunoblastic 17Burkitt Lymphoma 17Primary Myelofibrosis 16Neoplasms, Plasma Cell 16Leukemia, Myeloid, Accelerated Phase 16Congenital Abnormalities 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Lymphoma, T-Cell, Cutaneous 14Leukemia, Myelomonocytic, Chronic 14Leukemia, Myeloid, Chronic-Phase 14Graft vs Host Disease 14Blast Crisis 13Hematologic Neoplasms 12Waldenstrom Macroglobulinemia 11Sezary Syndrome 11Lymphoma, Extranodal NK-T-Cell 11

Interventions

Epoetin Alfa 7Darbepoetin alfa 6epoetin beta 4Lenalidomide 4Cyclophosphamide 4ACE-011 4fludarabine 3Busulfan 3thymoglobulin 2telapristone acetate 2luspatercept 2fludarabine phosphate 2Cyclosporine 2Antilymphocyte Serum 2AP 1903 reagent 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2vactosertib 1ruxolitinib 1roxadustat 1obinutuzumab 1ibrutinib 1fosphenytoin 1ferrous sulfate 1ferric gluconate 1ferric carboxymaltose 1eltrombopag 1angiotensin I (1-7) 1Whole-Body Irradiation 1Thiotepa 1Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Anemia × Antilymphocyte Serum × Clear all
NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Stanford University

Phase 2 Completed
44 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡